Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Terns Pharmaceuticals, Inc. Financials Banner

Terns Pharmaceuticals, Inc. Financials

TERN Stock Analysis

Page title

Section title

TERN Income Statement Key Metrics

  • Revenue(TTM)1.32 M
  • Gross Profit(TTM)404,000
  • EBITDA(TTM)-107.31 M
  • Net Income(TTM)-95.90 M
  • EPS Diluted(TTM)-1.3199999999999998

Decode TERN's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

TERN earnings and revenue history

TERN Return on Equity

See how efficiently TERN generates profit for it's shareholders.

-35.33%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of TERN (-0.353) is higher than the average of its peers (-0.748).

Return on Equity Growth

TERN's Return on Equity has shown poor growth over the past 10 years, increasing by only 6.27%.

TERN Revenue Growth

See how TERN has grown it's revenue over the past 10 years.


Revenue Growth

TERN's revenue has shown poor growth over the past 10 years, increasing by only 0%.

TERN FY, 2023 Revenue Breakdown

See how TERN converts it's revenue into profit.

TERN Balance Sheet Health

TERN Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

TERN financial position analysis

Short Term Liabilities

TERN's short term assets($267M) can safely cover it's short term liabilities($12M).

Long Term Liabilities

TERN's short term assets($267M) can safely cover it's long term liabilities($1M).

TERN Debt to Equity